Analyst consensus rating
DexCom Analyst Rating: Strong Buy
DXCM is rated Strong Buy by 25 analysts with a $94.12 target. As of 2026-09-02.
Direct answer
DexCom's consensus rating is Strong Buy.
25 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $94.12.
Forecast evidence checked September 2, 2026.
Get free DexCom email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $89.76
- Average price target
- $94.12
- High price target
- $115.00
- Low price target
- $79.00
- Low target gap
- -12%
- Target upside
- +4.9%
- High target gap
- +28.1%
- Target range width
- 40.1%
- Consensus rating
- Strong Buy
- Analysts
- 25
- Evidence date
- September 2, 2026
- Valid through
- September 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for DexCom?
DexCom has a verified Strong Buy consensus. The same dataset has an average price target of $94.12.
How far are DexCom's low and high targets from the recorded price?
The low target implies -12%, while the high target implies +28.1%.
How many analysts are included in DexCom's consensus?
The verified consensus includes 25 analysts.
How is DexCom's target upside or downside calculated?
The average target of $94.12 is divided by the recorded price of $89.76, then one is subtracted to produce +4.9%. This does not guarantee a future return.
When was DexCom's analyst forecast verified?
The data was verified on 2026-09-02. The dataset is valid through 2026-09-09.